BioPharm International-12-01-2003

What are the key challenges - and advances - in fermentation and cell culture technology that industry faces over the next five years?

As the various industry sectors expand drug discovery and development activities, there will be more direct competition as well as opportunities for collaboration.

FDA initiatives aim to spur development of more affordable treatments and ensure safe product use.

Bioconjugation chemistry is the joining of biomolecules to other biomolecules, small molecules, and polymers by chemical or biological means.

Publicly traded CROs and CMOs reported solid financial results in their most recent quarter, but the big news at October's AAPS meeting was the substantial rise in new RFPs and contracts.

Genomics companies have taken a beating on Wall Street. Will newly developed therapies like ABthrax help the sector return?